• Asia-Pacific Journal of Business
• /
• v.15 no.3
• /
• pp.233-251
• /
• 2024

Purpose - This study investigates whether the relationship between investment competition rates (institutional investors, general investors, employee stock ownership) in the KOSDAQ IPO market and stock price overreaction after a new listing is different depending on economic conditions (economic crisis and non-economic crisis). Design/methodology/approach - I set the stock price overreaction measured by subtracting the five-day cumulative excess return from the IPO first-day return as the dependent variable, and the investment competition rate by investor type as the explanatory variable. Then, I divided the sample by economic conditions and conducted a regression analysis. Findings - Unlike other investment competition rates, I find that the positive relationship between the IPO subscription competition rate of general investors and the post-IPO stock price overreaction increases during economic crises. Research implications or Originality - The findings of this study suggest that the inflow of individual investors seeking short-term performance into the KOSDAQ IPO market increases during economic crises, and their sentimental investment behavior increases the stock price overreaction after the IPO.

• Asia-Pacific Journal of Business
• /
• v.8 no.2
• /
• pp.1-14
• /
• 2017

Initial public offering (IPO) has been well known to be underpriced initially and under-performed in the long run. However, whether an IPO is underpriced or not strongly depends on how to measure the fair value. This paper hand collects data of IPOs newly listed in Korea market when whether IPO is overpriced or not is clearly distinguishable. The overpriced IPO refers to as the one the underwriters buy back after the listing. With the data, the paper examines that IPOs are overpriced and that the characteristics are related to the underpricing at the aftermarket dates and the performance in the long run. The data of clearly overpriced IPOs are little available from other IPO markets like US IPO market. From the data of IPOs listed under the underwriting rule of market stabilization, the results obtainable are the followings. First of all, the average initial return 70% of the underpriced IPO at the aftermarket dates is greater than the one 40% of the overpriced one. The overpriced IPOs are priced highly over the mid prices of the price bands at the pricing dates and then supported by relatively higher subscription rates of individual investors. The probit analyses moreover report that individual investors do not distinguish the overpricing of IPOs from the underpricing. These imply that the overpricing is strongly affected by the underwriting rule on the initial pricing.

• Journal of Contemporary Eastern Asia
• /
• v.21 no.1
• /
• pp.43-52
• /
• 2022

This study examines the impacts of a mandatory lockup ratio and lockup period, together with voluntary lockup, on the initial public offering (IPO) subscription rate in Malaysia. A sample of 390 IPOs launched from 2000 to 2016 was collected for analysis. The findings show that firms that adopt a lower lockup ratio and a shorter lockup period signal uncertainty about their prospects. Issuers would then show the tendency to underprice to increase investors' intention to subscribe to firms' IPO shares. This study concludes that as long as investors are aware of pertinent information about IPO firms, they should continue participating in the IPO market rather than behaving irrationally. Finally, policymakers could use the findings to improve the existing lockup provisions regulation.

• Asia-Pacific Journal of Business Venturing and Entrepreneurship
• /
• v.19 no.4
• /
• pp.55-67
• /
• 2024

This study aims to identify signals that can predict the quality of startups aiming to be listed on Korea's KOSDAQ market. The startups are divided into two groups: those backed by venture capital, where a third party has addressed information asymmetry, and those not backed by venture capital. The study seeks to identify signals to help select good companies for each group. The study primarily focuses on underpricing, which strongly correlates with company quality. It aims to investigate the causal relationship between underpricing and independent variables such as underwriter reputation, institutional investor competition rate, locked-up share ratio, and extended lockup period. The empirical analysis shows that IPOs with high institutional investor subscription competition, IPOs of start-ups without VC backing matched with reputable lead managers, and IPOs with high lockup shares of start-ups with VC backing are significantly underpriced. This study provides a theoretical and logical basis for strategically choosing the level of underpricing, considering the circumstances of the firm going public, mainly whether it is VC-backed or not, and considering the effectiveness of other signals mentioned above. It also opens the door for further research by researchers in other regions to study institutional investors' subscription ratio as the pre-listing signal that can help address information asymmetry. From a policymaker's perspective, the disclosure of the above information can be considered to reduce information asymmetry for investors.

• Asia-Pacific Journal of Business Venturing and Entrepreneurship
• /
• v.14 no.1
• /
• pp.151-166
• /
• 2019

New drug development requires 10 to 15 years of long time and more than $ 1 billion in funding, ranging from basic research${\rightarrow}$preclinical medicine${\rightarrow}$clinical medicine${\rightarrow}$product approval${\rightarrow}$sales. Many new drug development bio-venture companies will continue to pursue new drug development with funds secured through listing on the securities market. This study focuses on the impact of the listing on the market of bio-venture companies in the development of new drugs. It is necessary to determine whether the increase in registered patent, preclinical, clinical and technology transfer contracts at the time of listing (D) The results of this study are as follows. We also analyzed whether the registered patent, preclinical, and clinical effects had significant effect on technology transfer contracts at two years after listing and listing. The results of the analysis are as follows. First, Korea's new drug development bio-venture firms increased their registered patents but did not increase their pre-clinical, clinical and technology transfer contracts. Second, at the time of listing and two years after listing, pre-employment has a significant effect on Korea's technology transfer contracts and has a significant effect on overseas technology transfer contracts. However, registered patents and clinics have significant influence on technology transfer contracts. Korea 's new drug development bio-venture firms showed patent increase despite the stock market listing, but pre-clinical, clinical and technology transfer contracts did not increase. In order to strengthen technological commercialization of new drug development bio-venture companies in the future, it is required to establish R & D strategy for efficient use of IPO subscription funds, open innovation through strengthening industry-academia-partnerships, and more sophisticated preclinical and clinical strategy establishment.